Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)
Clinical trial NCT04458051 · COMPLETED
Trial details
- NCT number
- NCT04458051
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2025-11-14
- Enrollment
- 767
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.